Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. DEF 14A Proxy Proxy Statement
  5. DEF 14A Proxy Proxy Statement
  6. DEF 14A Proxy Proxy Statement
  7. DEF 14A Proxy Proxy Statement
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 11 filings